1. Home
  2. MYN vs SMTI Comparison

MYN vs SMTI Comparison

Compare MYN & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniYield New York Quality Fund Inc.

MYN

Blackrock MuniYield New York Quality Fund Inc.

N/A

Current Price

$8.86

Market Cap

349.0M

Sector

Finance

ML Signal

N/A

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

N/A

Current Price

$34.86

Market Cap

313.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYN
SMTI
Founded
1992
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.0M
313.5M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
MYN
SMTI
Price
$8.86
$34.86
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
★ $35.00
AVG Volume (30 Days)
★ 330.9K
181.9K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
★ 4.12%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $15,586,976.00
Revenue This Year
N/A
$13.07
Revenue Next Year
N/A
$14.23
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 32.47
52 Week Low
$8.68
$16.05
52 Week High
$10.26
$35.34

Technical Indicators

Market Signals
Indicator
MYN
SMTI
Relative Strength Index (RSI) 30.85 64.96
Support Level N/A $33.99
Resistance Level $10.03 $35.34
Average True Range (ATR) 0.14 0.20
MACD -0.01 -0.16
Stochastic Oscillator 29.37 50.79

Price Performance

Historical Comparison
MYN
SMTI

About MYN Blackrock MuniYield New York Quality Fund Inc.

BLACKROCK MUNIYIELD N Y QUALITY FD INC is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: